Skip to content
Nonprofiteer
← NEW YORK GENOME CENTER INC

Form 990 for tax year 2024

Filed by NEW YORK GENOME CENTER INC.

Totals

Total revenue
$82,342,631
Total expenses
$84,343,480
Contributions and grants received
$75,537,348
Grants paid
$2,986,182
Program service revenue
$4,904,919
Investment income
$360,077
Other revenue
$1,540,287
Total assets, end of year
$166,954,755
Total liabilities, end of year
$123,038,215
Net assets or fund balances, end of year
$43,916,540
Program services expenses (Part IX)
$68,153,855
Management and general expenses
$14,860,197
Fundraising expenses
$1,329,428
Program service expenses (Part III)
$68,153,855

Program services were 80.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1b · Membership dues

    $2,435,000

  • 1e · Government grants (contributions)

    $22,350,611

  • 1f · All other contributions, gifts and grants

    $50,751,737

  • 1g · Noncash contributions included above

    $310,488

  • 2a · Program service revenue: RESEARCH SEQUENCING

    total $4,233,105 · related or exempt $3,416,613 · unrelated business $816,492

  • 2b · Program service revenue: CLINICAL SEQUENCING

    total $671,814 · related or exempt $671,814

  • 3 · Investment income

    total $100,871 · excluded $100,871

  • 5 · Royalties

    total $1,683,278 · excluded $1,683,278

  • 6a · Gross rents

    real property $4,563,829

  • 6b · Less rental expenses

    real property $5,428,906

  • 6c · Rental income or loss

    real property -$865,077

  • 6d · Net rental income or loss

    total -$865,077 · excluded -$865,077

  • 7a · Gross sales of assets other than inventory

    securities $259,206

  • 7b · Less cost or other basis and sales expenses

    securities $0

  • 7c · Gain or loss

    securities $259,206

  • 7d · Net gain or loss

    total $259,206 · excluded $259,206

  • 11a · Other revenue: EDC LOAN RECOGNITION

    total $722,086 · excluded $722,086

  • 11e · Other revenue, total

    $722,086

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $2,668,307 · program services $2,668,307

  • 3 · Grants to foreign organizations and individuals

    total $317,875 · program services $317,875

  • 5 · Compensation of officers, directors and key employees

    total $4,365,188 · program services $1,956,771 · management and general $1,802,707 · fundraising $605,710

  • 7 · Other salaries and wages

    total $25,603,693 · program services $19,579,840 · management and general $5,629,217 · fundraising $394,636

  • 8 · Pension plan contributions

    total $1,526,695 · program services $1,130,593 · management and general $349,052 · fundraising $47,050

  • 9 · Other employee benefits

    total $3,096,722 · program services $2,456,982 · management and general $613,345 · fundraising $26,395

  • 10 · Payroll taxes

    total $3,362,009 · program services $2,683,383 · management and general $616,019 · fundraising $62,607

  • 11b · Fees: legal

    total $455,423 · management and general $455,423

  • 11c · Fees: accounting

    total $141,144 · management and general $141,144

  • 11d · Fees: lobbying

    total $60,000 · management and general $60,000

  • 11e · Fees: professional fundraising services

    total $788 · fundraising $788

  • 11g · Fees: other

    total $2,615,838 · program services $2,515,327 · management and general $100,511

  • 13 · Office expenses

    total $505,494 · program services $243,048 · management and general $254,990 · fundraising $7,456

  • 14 · Information technology

    total $4,277,629 · program services $3,862,562 · management and general $415,067

  • 15 · Royalties

    total $360,696 · program services $360,696

  • 16 · Occupancy

    total $13,258,040 · program services $10,612,675 · management and general $2,532,183 · fundraising $113,182

  • 17 · Travel

    total $457,045 · program services $406,595 · management and general $48,880 · fundraising $1,570

  • 19 · Conferences, conventions and meetings

    total $107,362 · program services $80,790 · management and general $24,311 · fundraising $2,261

  • 20 · Interest

    total $290,077 · program services $195,569 · management and general $92,887 · fundraising $1,621

  • 22 · Depreciation, depletion and amortization

    total $6,565,363 · program services $6,207,285 · management and general $319,367 · fundraising $38,711

  • 23 · Insurance

    total $797,641 · management and general $797,641

  • 24a · Other expenses: DIRECT COST OF SEQUENCI

    total $9,324,415 · program services $9,324,415

  • 24b · Other expenses: RESEARCH

    total $3,376,498 · program services $3,376,498

  • 24c · Other expenses: RECRUITMENT

    total $332,450 · program services $19,202 · management and general $313,248

  • 24e · All other expenses

    total $477,088 · program services $155,442 · management and general $294,205 · fundraising $27,441

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $9,326,778 · end of year $5,408,177

  • 2 · Savings and temporary cash investments

    beginning of year $3,505,459 · end of year $4,402,079

  • 3 · Pledges and grants receivable

    beginning of year $18,649,498 · end of year $16,784,952

  • 4 · Accounts receivable

    beginning of year $7,382,860 · end of year $7,076,051

  • 8 · Inventories for sale or use

    beginning of year $1,607,153 · end of year $1,429,249

  • 9 · Prepaid expenses and deferred charges

    beginning of year $2,491,274 · end of year $2,478,585

  • 10a · Land, buildings and equipment: cost or other basis

    $146,378,144

  • 10b · Land, buildings and equipment: accumulated depreciation

    $102,893,087

  • 10c · Land, buildings and equipment, net

    beginning of year $46,071,277 · end of year $43,485,057

  • 15 · Other assets

    beginning of year $95,017,931 · end of year $85,890,605

  • 17 · Accounts payable and accrued expenses

    beginning of year $7,098,614 · end of year $5,863,554

  • 19 · Deferred revenue

    beginning of year $14,803,697 · end of year $13,422,281

  • 24 · Unsecured notes and loans payable

    beginning of year $2,660,000 · end of year $1,940,000

  • 25 · Other liabilities

    beginning of year $113,573,845 · end of year $101,812,380

  • 27 · Net assets without donor restrictions

    beginning of year $20,204,925 · end of year $14,697,417

  • 28 · Net assets with donor restrictions

    beginning of year $25,711,149 · end of year $29,219,123

Mission and programs · 2024

Mission

OPERATE A STATE-OF-THE-ART, WORLD-CLASS GENOMIC RESEARCH CENTER THAT CREATES AND USES ADVANCED GENOMICS TO UNDERSTAND THE GENETIC BASIS OF DISEASE. FOR MORE INFORMATION, SEE SCHEDULE O.

Activities or mission (Part I)

PROVIDING GLOBAL LEADERSHIP IN HUMAN GENOME RESEARCH AND ITS TRANSLATION INTO CLINICAL CARE.

  • GENOME SEQUENCING: THE NEW YORK GENOME CENTER (NYGC) HAS ONE OF NEW YORK'S LARGEST AND MOST ADVANCED WHOLE GENOME SEQUENCING PROGRAMS, HAVING SEQUENCED OVER 106,885 WHOLE GENOME SAMPLES TO DATE. NYGC'S TWO STATE-OF-THE-ART ILLUMINA NOVASEQ X SYSTEMS SEQUENCERS ARE EACH CAPABLE OF SEQUENCING 20,000 HUMAN GENOMES ANNUALLY. THIS STATE-OF-THE-ART SEQUENCING TECHNOLOGY ENABLES NYGC TO CONDUCT LARGE-SCALE GENOMICS PROJECTS WITH GREAT SPEED AND SAMPLE VOLUMES, AND TO EXPLORE THE GENOME IN MORE DEPTH WITH GREATER EFFICIENCY. IN ADDITION, NYGC OPERATES AN OXFORD NANOPORE PROMETHION SEQUENCER FOR LONG READ SEQUENCING, AND A HIGH-THROUGHPUT SEQUENCER FROM ULTIMA GENOMICS (THE UG100). SEE SCHEDULE O.

    Expenses $60,479,500 · Grants $2,986,182 · Revenue $4,233,105

  • CLINICAL SEQUENCING: NYGC'S CLEP/CLIA CERTIFIED CLINICAL LABORATORY IS AUTHORIZED BY THE NEW YORK STATE DEPARTMENT OF HEALTH TO OFFER THE FOLLOWING APPROVED CLINICAL TESTS: CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR UNDIAGNOSED DISEASE, CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR PREDISPOSITIONAL GENETIC SCREENING, ONCOLOGY WHOLE GENOME AND TRANSCRIPTOME SEQUENCING, TARGETED VARIANT TESTING USING SANGER SEQUENCING, MATERNAL CELL CONTAMINATION TESTING, AND ANEUPLOIDY SCREENING.

    Expenses $7,674,355 · Revenue $671,814

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • TOM MANIATIS PHD

    SCIENTIFIC DIRECTOR & CEO

    Total calculated
    $675,040
    From this org
    $675,040
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $675,040
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $675,040

  • RUSSELL L CARSON MBA

    DIRECTOR & CHAIRMAN

    Total calculated
    $0
    Hours/week
    1

  • IVAN G SEIDENBERG MBA

    DIRECTOR & CO-CHAIR

    Total calculated
    $0
    Hours/week
    1

  • HERB PARDES MD

    DIR. & EXEC. VICE CHAIR (ENDED 4/24)

    Total calculated
    $0
    Hours/week
    1

  • BRUCE STILLMAN PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • KATRINA ARMSTRONG MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • SELWYN M VICKERS MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • DENNIS S CHARNEY MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • DAFNA BAR-SAGI PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • KEVIN J TRACEY MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • KENNETH A DILL PHD

    DIRECTOR (ENDED 10/24)

    Total calculated
    $0
    Hours/week
    1

  • RICHARD P LIFTON MD PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • BARBARA ROSATI PHD

    DIRECTOR (STARTED 10/24)

    Total calculated
    $0
    Hours/week
    1

  • ROBERT A HARRINGTON MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • ELI CASDIN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • NICHOLAS DONOFRIO

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JOSEPH E EDELMAN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JOHN B EHRENKRANZ

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • ANTHONY B EVNIN PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JOHN P HAVENS

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • WESLIE R JANEWAY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • ALONDRA NELSON PHD

    DIRECTOR (STARTED 6/24)

    Total calculated
    $0
    Hours/week
    1

  • FRANK V SICA

    DIRECTOR & COMMITTEE CHAIR

    Total calculated
    $0
    Hours/week
    1

  • DAVID N SPERGEL PHD

    DIRECTOR (STARTED 3/24)

    Total calculated
    $0
    Hours/week
    1

  • JIM SIMONS PHD

    DIRECTOR (THROUGH 5/24)

    Total calculated
    $0
    Hours/week
    1

  • NANCY A THORNBERRY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • STEVEN J CORWIN MD

    DIRECTOR (STARTED 6/24)

    Total calculated
    $0
    Hours/week
    1

  • ELIZABETH BROOKS O'BRIEN

    VP & GENERAL COUNSEL

    Total calculated
    $514,532
    From this org
    $468,516
    From related orgs
    $0
    Other
    $46,016
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $468,516
    Bonus
    $0
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $25,316
    Filer's total
    $514,532

  • MARIA JOANTA

    CHIEF FINANCIAL OFFICER

    Total calculated
    $437,226
    From this org
    $385,785
    From related orgs
    $0
    Other
    $51,441
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $341,190
    Bonus
    $0
    Other
    $44,595
    Deferred
    $20,700
    Nontaxable benefits
    $30,741
    Filer's total
    $437,226

  • SARAH LESSER AVINS

    SVP, ADVANCEMENT & CHIEF D

    Total calculated
    $605,710
    From this org
    $566,991
    From related orgs
    $0
    Other
    $38,719
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $566,991
    Bonus
    $0
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $18,019
    Filer's total
    $605,710

  • SOREN GERMER

    SVP, GENOME TECHNOLOGIES

    Total calculated
    $478,436
    From this org
    $439,717
    From related orgs
    $0
    Other
    $38,719
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $439,717
    Bonus
    $0
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $18,019
    Filer's total
    $478,436

  • CAROL ASHE

    CHIEF BUSINESS OFFICER

    Total calculated
    $459,632
    From this org
    $438,815
    From related orgs
    $0
    Other
    $20,817
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $438,815
    Bonus
    $0
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $117
    Filer's total
    $459,632

  • MICHAEL CHARLES ZODY

    SCIENTIFIC DIR, COMP BIOLO

    Total calculated
    $401,917
    From this org
    $371,713
    From related orgs
    $0
    Other
    $30,204
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $371,713
    Bonus
    $0
    Other
    $0
    Deferred
    $20,700
    Nontaxable benefits
    $9,504
    Filer's total
    $401,917

  • THOMAS LEHNER

    SCI DIR, NEURO DG (THROUGH 11/24)

    Total calculated
    $401,378
    From this org
    $372,482
    From related orgs
    $0
    Other
    $28,896
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $343,152
    Bonus
    $0
    Other
    $29,330
    Deferred
    $13,396
    Nontaxable benefits
    $15,500
    Filer's total
    $401,378

  • CHARLES GAGNON

    CHIEF INFORMATION OFFICER

    Total calculated
    $391,317
    From this org
    $341,546
    From related orgs
    $0
    Other
    $49,771
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $341,546
    Bonus
    $0
    Other
    $0
    Deferred
    $17,590
    Nontaxable benefits
    $32,181
    Filer's total
    $391,317

  • SHAILAJA GARGEYA

    SENIOR DIR, SOFTWARE ENGIN

    Total calculated
    $370,033
    From this org
    $349,593
    From related orgs
    $0
    Other
    $20,440
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $329,545
    Bonus
    $950
    Other
    $19,098
    Deferred
    $20,323
    Nontaxable benefits
    $117
    Filer's total
    $370,033

  • DAYNA M OSCHWALD

    CHIEF OF STAFF

    Total calculated
    $330,086
    From this org
    $294,329
    From related orgs
    $0
    Other
    $35,757
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $294,329
    Bonus
    $0
    Other
    $0
    Deferred
    $17,813
    Nontaxable benefits
    $17,944
    Filer's total
    $330,086

  • CHRISTOPHER PHIFER BLACK

    SR. DIR., RESEARCH COMP.

    Total calculated
    $309,250
    From this org
    $263,806
    From related orgs
    $0
    Other
    $45,444
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $263,806
    Bonus
    $0
    Other
    $0
    Deferred
    $16,263
    Nontaxable benefits
    $29,181
    Filer's total
    $309,250

  • AVINASH VIJAY ABHYANKAR

    DIRECTOR, CLINICAL BIOINFORM.

    Total calculated
    $301,273
    From this org
    $259,321
    From related orgs
    $0
    Other
    $41,952
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $259,321
    Bonus
    $0
    Other
    $0
    Deferred
    $15,947
    Nontaxable benefits
    $26,005
    Filer's total
    $301,273

  • CATHERINE E REEVES

    SR. DIR., SEQUENCING OPERATIONS

    Total calculated
    $278,021
    From this org
    $241,489
    From related orgs
    $0
    Other
    $36,532
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $241,489
    Bonus
    $0
    Other
    $0
    Deferred
    $15,413
    Nontaxable benefits
    $21,119
    Filer's total
    $278,021

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Independent compensation consultant
  • 3 · Approval by the board or compensation committee
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 3
IN 2024, NYGC'S SCIENTIFIC DIRECTOR & CEO WAS EMPLOYED BY AN UNRELATED ENTITY AND LEASED TO NYGC TO DEVOTE 80% OF HIS TIME AND EFFORT TO SERVING AS NYGC'S SCIENTIFIC DIRECTOR & CEO, AN OFFICER OF THE CORPORATION, AND AS A SENIOR ASSOCIATE MEMBER OF NYGC'S FACULTY, WITH RESPONSIBILITY FOR OVERSEEING NYGC'S RESEARCH PROGRAMS AND FOR UNDERTAKING SUCH OTHER ACTIVITIES AS NYGC'S BOARD OF DIRECTORS REQUESTED FROM TIME TO TIME. THE SCIENTIFIC DIRECTOR & CEO DEVOTED THE REMAINING 20% OF HIS TIME TO HIS OWN RESEARCH LABORATORY AT THE UNRELATED ENTITY, WHERE HE MAINTAINED A LABORATORY AND CONDUCTED INDEPENDENT, INVESTIGATOR-INITIATED RESEARCH PROJECTS. IN 2024, NYGC HIRED AN INDEPENDENT COMPENSATION CONSULTANT TO PERFORM AN EXECUTIVE TOTAL COMPENSATION STUDY OF SENIOR MANAGEMENT'S COMPENSATION, INCLUDING THE SCIENTIFIC DIRECTOR & CEO. THE REVIEW SHOWED THAT THE COMPENSATION PAID TO ALL MEMBERS OF SENIOR MANAGEMENT, INCLUDING THE SCIENTIFIC DIRECTOR & CEO WAS REASONABLE.
PART I, LINE 7
CERTAIN INDIVIDUALS LISTED ON SCHEDULE J, PART II RECEIVED DISCRETIONARY BONUSES IN 2024.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Provenance

Return type
form_990
Tax year
2024
Filed
31 October 2025
IRS schema version
2024v5.2
Source object
202533099349302893

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.